Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
McKesson
Harvard Business School
Baxter
Merck

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Claims for Patent: 9,610,430

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,610,430
Title:Cell spraying device, method and sprayed cell suspension
Abstract: The invention provides a device and methods suitable for producing a cellular spray of cells. The sprayed cells are of interest for covering and growing on a surface, including a skin wound. In applying the method and/or using the device, cells for grafting onto a patient are dispersed in a solution and sprayed with the device for distribution over the recipient\'s graft site.
Inventor(s): Bornemann; Reinhard (Bielefeld, DE)
Assignee: RenovaCare Sciences Corp. (New York, NY)
Application Number:14/136,681
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,610,430
Patent Claims:1. A method to treat a wounded area of skin on a human subject, comprising: providing a single cell-suspension of cells comprising progenitor skin cells in a serum-free physiological solution in a sterilizable container, wherein the cells are obtained from the subject's normal skin tissue that has been treated with enzymes so as to release the cells from the dermal-epithelial cell junction, wherein the skin cells have not been subjected to ex vivo or in vitro expansion; contacting the single-cell suspension of cells with a gas flow at an outlet of the container to create droplets of the suspension at a flow-controlled spray head; and spraying the droplets onto the wounded area of skin without forming a closed cell sheet so that the single cells are distributed directly and evenly and the cells regenerate normal skin by in situ multiplication to heal the wounded area in the absence of applying a preformed skin graft.

2. The method of claim 1 wherein the suspension comprises uncultured cell types in a ratio comparable to that found in normal skin.

3. The method of claim 1 or 2 wherein the cells comprise basal keratinocytes, Langerhans cells, fibroblasts and melanocytes.

4. The method of claim 1 wherein the cells in the suspension have a morphology that is similar to the cells in the droplets.

5. The method of claim 2 wherein the suspension comprises skin progenitor cells.

6. The method of claim 1, wherein the suspension is filtered to remove large cellular congregates.

7. The method of claim 6, wherein the filter has a cut-off of 5-100 cell congregates.

8. The method of claim 1 wherein the enzymes comprise dispase and trypsin.

9. The method of claim 1 wherein the enzymes comprise collagenase.

10. The method of claim 1 wherein the container is a syringe and the suspension is delivered to the outlet of the spray head by continuous force application to the container.

11. The method of claim 1 wherein the wounded area is burned.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Colorcon
McKesson
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.